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Abstract
Background: Malaria is an important threat to travelers visiting endemic regions. The risk of
acquiring malaria is complex and a number of factors including transmission intensity, duration of
exposure, season of the year and use of chemoprophylaxis have to be taken into account estimating
risk.
Materials and methods: A mathematical model was developed to estimate the risk of non-
immune individual acquiring falciparum malaria when traveling to the Amazon region of Brazil. The
risk of malaria infection to travelers was calculated as a function of duration of exposure and season
of arrival.
Results: The results suggest significant variation of risk for non-immune travelers depending on
arrival season, duration of the visit and transmission intensity. The calculated risk for visitors staying
longer than 4 months during peak transmission was 0.5% per visit.
Conclusions: Risk estimates based on mathematical modeling based on accurate data can be a
valuable tool in assessing risk/benefits and cost/benefits when deciding on the value of interventions
for travelers to malaria endemic regions.
Introduction
The risk of malaria for visitors to the nine Brazilian states
of the Legal Amazon region - Acre, Amapá, Amazonas,
Maranhão (western part), Mato Grosso (northern part),
Pará (except Belém City), Rondônia, Roraima and
Tocantins (western part) - is predominantly P. vivax
(75%) with P. falciparum making up the remainder one
quarter of surveillance reports. In addition, it should be
noted that multidrug-resistant P. falciparum has been
reported [1] in the same region. Transmission occurs in
most forested areas below 900 m though there is some
urban transmission around settlements and small cities in
the region. Transmission intensity varies according to the
season and municipality. It is higher in jungle areas where
recent (<5 years) mining, lumbering and agricultural set-
tlements than in urban areas, such as larger cities like Boa
Vista, Macapá, Manaus, Maraba, Pôrto Velho, Rio Branco
and Santarém, where transmission occurs on their out-
skirts. However, in the central areas of these cities trans-
mission is negligible or non-existent.
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In 2007 Brazil reported approximately 50% of the total
number of the malaria cases in the Americas. Ninety-nine
percent of those cases were from the Legal Amazon, where
10% to 15% of the population of Brazil population live
[2]. Case numbers fell between 1992 to 2002 from
572,000 to 349,873, with around 16.5% of all the slides
examined resulted positive for malaria. A rebound
occurred between 2003 to 2007 with number of cases
peaking at 607,000 in 2005 and 458,041 cases in 2007.
All reported malaria cases were confirmed by laboratory
analysis, and 19% in 2007 were P. falciparum. Theses cases
were predominantly associated with population move-
ment to the periphery of large cities in the Legal Amazon
Region [2]. Therefore, the average burden of malaria over
the last decade has been approximately 600,000 cases per
year, with the proportion of falciparum around 20% ot
total [3]. WHO estimated the total numbers of malaria
cases in 2006 as approximately 1.4 million [2]. The differ-
ence between the two figures reflects either an underesti-
mation (Brazilian official data) or an overestimation of
the actual number of cases (WHO estimates). The true val-
ues probably lies between the two.
Brazil has the second largest number of foreign visitors in
Latin America after Mexico [4]. In 2005 Brazil recorded
5.4 million international arrivals with 57% of these
traveling coming from North America and Europe [5]. Of
the total, 44% were leisure tourists. Preliminary analysis
of tourism arrivals for 2004/2005 by Embratur [5], reveal
that 39% of tourists cite Brazil's natural beauty as their
reason for travel. However, 7% of leisure tourists ((3% of
total tourists) state they visited the Brazilian Amazon.
Therefore, estimated visits to the malaria endemic areas of
Brazil are of the order of 160,000 per year. Embratur [5]
identifies that tourists from the domestic market is much
larger. The latest study indicates that of the annual 11 mil-
lion domestic Brazilian travelers, around 300,000 visit the
Amazon region. Therefore an estimated half a million
non-resident visitors are exposed to malaria per year in
this region [4].
Malaria prevention in non-immune travelers is based on
chemoprophylaxis, recommended for all visitors to the
region where there is active malaria transmission. How-
ever, all regimens have well recognized and not infrequent
side effects, including severe events that interfere with rou-
tine daily activity. Therefore risk-management requires
the balance of risk of infection and risk of toxicity when
prescribing chemoprophylaxis. This balance is particu-
larly important when the risk of malaria is low and the
numbers exposed are significant [6].
This study was designed to use a mathematical model to
estimate the risk of acquiring falciparum malaria for trave-
lers to the endemic regions of Brazil.
The Model
The model assumes that the population of humans is sub-
divided into three classes and the population of mosqui-
toes is similarly divided into three compartments
summarized in table S1, Additional file 1. It was separated
from the human general population (individuals that are
in the area) a cohort [7], denoted by primes and named
"probe", which represent a cohort of travelers, followed
through their entire exposure in the region, to calculate
the risk of malaria acquisition.
The model's dynamics is described by the set of equations
shown in the appendix.
A deterministic version (precisely determined through a
known relationship) of the model was used to describe
the malaria dynamics in the resident population level and
a stochastic version (using a ranges of variable values pro-
viding a probability). On the equations analyzing the
probes to describe the risk (probability of contracting
malaria) of a single individual traveler visiting the region.
This is based on the assumption that, since the probe is a
small number of individuals, the biting rate will ran-
domly fluctuate and the probability of infection is unpre-
dictable.
The model's parameters are: a is the mosquitoes daily bit-
ing rate; a' is the mosquitoes daily biting rate in the probe;
b is the proportion of infected bites that are actually infec-
tive to humans; b' is the proportion of infected bites that
are infective to humans in the probe; c is the proportion
of bites that are infective for mosquitoes; μH is the humans
mortality rate; γH is the humans recovery rate from parasi-
taemia; rH is the humans birth rate; αH is the malaria-
induced mortality rate of humans; σH is the lost of immu-
nity due to malaria; μM is the mosquitoes daily mortality
rate, τ is the extrinsic incubation period; rM is the mosqui-
toes fertility rate; κH is the humans carrying capacity and
κM is the mosquitoes carrying capacity. We introduced the
term [cS-dSsin(2πft)] in the susceptible mosquitoes popu-
lation in order to simulate seasonality in the mosquitoes
population [8,9]. The parameters cS and dS (cS >dS) vary
the intensity by seasonality, mimicking severe or mild
winters, through adjusting these parameters' values. The
model parameters are shown in table S2, Additional file 2.
The seasonality parameters cS and dS where chosen to rep-
resent the observed seasonal variation in the Amazon
region described by Tadei [10], who described a 30 fold
difference in mosquito number between summer and
winter.
Using the parameters in table S1, Additional file 1 the
model calculates that around 250,000, falciparumMalaria Journal 2009, 8:296 http://www.malariajournal.com/content/8/1/296
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malaria cases will occur annually, a number similar to
WHO estimates for Brazil in 2006 [2].
Estimating the risk of malaria
In order to calculate the probability of an individual
acquiring malaria infection, πmal after the introduction of
a single case in an entirely susceptible population it was
considered the probe (travelers within the region) fol-
lowed through an entire outbreak. The probability of
infection in this self-limiting outbreak is then given by the
following expression:
In the above equation, S'H(t) and N'H(t) are respectively
the number of susceptible hosts and the total population
of the cohort used as a probe, and hmal(t) is the force of
infection of malaria, defined as the per capita number of
new cases per time unit [7] and expressed as
where IM(t) is the number of infected mosquitoes.
One can also calculate the average risk (probability) of
infection for a traveler who arrives in the affected region at
week Ω after the outbreak is triggered and remains there
for ω weeks,  . This is done by setting the limits of
integration in equation (1) as:
The average risk for a traveler who arrived in the Amazo-
nian region at four different time periods was calculated,
namely, in the dry season (winter) in the spring, in the wet
season (summer) and in the fall. The model produces a
result of 250,000 cases falciparum malaria per year. This
number is very dependent on a number of other variables
and parameters. In the sensitivity analysis below all the
parameters are varied and as a consequence the yearly
number of cases varies. The result for the risk calculation
is shown in figure 1.
Sensitivity analysis
In this section we analyze the sensitivity of the model to
the parameters. This is done in two steps: a deterministic
analysis at the populational level, which describes the sen-
sitivity of the model to measurement variance in the
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Stochastic risk of catching falciparum malaria for travelers as a function of the period of the year they arrive and the time  remaining in the area (the figure shows 20 iterations of the 1000 simulated) Figure 1
Stochastic risk of catching falciparum malaria for travelers as a function of the period of the year they arrive 
and the time remaining in the area (the figure shows 20 iterations of the 1000 simulated).Malaria Journal 2009, 8:296 http://www.malariajournal.com/content/8/1/296
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parameters; and a stochastic analysis at the individual
level, which determines the variation in the model's out-
comes due to intrinsic stochasticity in some of the param-
eters.
Sensitivity of the model to variance in the parameters 
measures
The risk of malaria acquisition π as given by equation (3)
is a function of a number of parameters collectively
denoted by Pari. For a small variation of Pari, ΔPari, the
variation in the risk π, Δπ, is given by the well-known
error-propagation formula [11]:
The relative variation in the risk π, Δπ/π, as a function of
the relative variation in the parameters ΔPari/Pari, is there-
fore:
The result of this analysis is given in table S3, Additional
file 3.
The sensitivity of the model is significantly influenced by
with the season of the year. The two parameters that are
most influential in the model i are the biting rate a and the
mosquitoes mortality rate μM. Biting rate and mosquito
mortality are well recognized by entomologists as impor-
tant parameters as they describe vectorial capacity (a
quadratic component) and mortality expressed exponen-
tially in the equation.
Variation in the model's outcomes due to intrinsic 
stochasticity in some of the parameters
Of all the parameters described in table S1, Additional file
1 the biting rate a single individual is subject, a', and the
probability that an infectious biting is infective to the
individual, b', for an occasional traveler are obviously sto-
chastic variables. As mentioned above, it was assumed a
Poisson distribution for the parameter a' and a Gamma
distribution for the parameter b' with a small variance.
The result is shown in table S4, Additional file 4 which
shows the risk of malaria acquisition for a traveler who
arrives at different moments of the year and remains 30
days in the area.
The highest risk of malaria acquisition occurs for individ-
uals arriving in autumn (around one case for every 500
visitors) as the infected mosquitoes population is close to
its peak and the proportion infected high (see figure 2).
Where an individual remains for a 1 year their risk is
approximately 1.10 × 10-2 ± 2.75 × 10-5, that is, a relative
error of ± 0.25%. This rate closely correlates with the inci-
dence observed in Amazon residents of 1.16 × 10-2 per
person-year. PAHO [12] estimates that this incidence, a
maximum of 75 malaria cases per 1000 inhabitants annu-
ally will occur. We are estimating only the cases of falci-
parum malaria, which represent about one third of the
total malaria cases, hereby total predicted P falciaprum
malaria cases for this region is of the order of 33 cases per
1000 inhabitants per year.
Discussion
Mathematical models for estimating risks, as described in
this paper, should be considered as auxiliary tools for
decision-makers. Some caveats, however, are necessary;
the model's outcomes are determined by assumptions in
the dynamics of the system modeled and on the values
given to the parameters. In our model, the most critical
assumptions relate to homogeneity. For example, the
Amazon region is very large and therefore, it is likely that
some parameters will vary from region to region, such as
the densities of vectors and human hosts (determined by
the respective carrying capacities). The seasonal variations
assumed in the model are simple and are only an approx-
imation of the actual climatic variations that occur in the
Amazon region. Notwithstanding the oversimplifications
of our model, we believe that our results are a good
approximation in the sense that the actual risk of malaria
lies within the estimated confidence intervals calculated
by the model.
Previous studies have attempted to determine the cumu-
lative risk of acquiring malaria in travelers [6,13,14], but
the estimated incidence rates were not generalizable to all
travelers at all times, as malaria incidence varies greatly
from year to year [15].
Mathematical modeling is well suited to adjust for season-
ality and annual variations. In a previous analysis we
modeled the risk of dengue and yellow fever, with similar
approach to the one described here [16-18]. This is the
first time that travelers' malaria risk estimates have been
calculated using mathematical modeling. Our models are
robust and have been tested extensively on Amazonian
data [19]. Risk for malaria risk for endemic populations
has also been estimated using modeling by Okell et.al
[20].
The analysis presented quantifies the risk for non-
immune travelers visiting the Amazonian region, adjust-
ing by season and/or epidemic cycle.
A traveler arriving in summer (Dec-Feb) exposed for 120
days has at least a ten-fold higher risk of infection than a
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traveler who arrives in the winter (June-Aug) for a visit of
similar duration. It is shown that the risk increases nonlin-
early with time, but this again varies by season of expo-
sure.
National and international recommendations for long
term travelers; particularly those traveling through regions
of varying transmission and with different malaria species
have been very crude (all or nothing) and have a very lim-
ited evidence base [21].
The model can be used for highlighting the malaria risk in
a way that many advisors and their clients can interpret.
An individual arriving during the summer (Jan-Mar), that
is, rainy season, has a probability of 0.00015 (1:6666) of
being infected within a week of arrival if totally unpro-
tected whilst it takes approximately 3 months for a trave-
ler arriving during the winter months (Jun-Aug), that is,
dry season, to be infected with the same likelihood, with
intermediary values for arrivals during other seasons. In
fact, Behrens et al. [22] estimated the incidence of malaria
in UK travelers to Brazil as 1 case per 3000 person-years
exposed over the years 2000-2005. During this period
there were 394,559 visits with average visit duration of
22.5 days resulting in 9 vivax cases and no P falciparum
cases in UK travelers. Running the model with this data
the model produced a result of 1 case of falciparum
malaria. Assuming that travel was predominantly during
the winter months, this single case is a similar incidence
(0) as observed in UK travelers, affirming the reliability of
our current assumptions and values used in the model.
The model does not take account of pre-existing malaria
immunity although for most naïve travelers this is not
important. Another aspect that was not considered in this
paper is chemoprophylaxis, which is about 95% efficient
against falciparum malaria. Therefore, if only 50% of the
travelers are compliant, then the number of expected cases
is reduced by approximately 48%, although the risk for a
non-treated individual does not change.
It is important to stress what is gained in terms of risk esti-
mation with our model. It is known that the annual inci-
dence of malaria among Amazon residents is of the order
of 50 cases per 1000 inhabitants. This figure can be used
as a proxy for the risk to travelers staying for at least one
year in the region. However, the model provides estima-
tions of the risk for travels of shorter durations and, since
the risk for these short visits is dependent on the season of
In the figure we show in the x-axis time in days Figure 2
In the figure we show in the x-axis time in days. It starts arbitrarily at day 500 and illustrates seasonal variation of a mos-
quito population (susceptible and infected). The arrows define the relative season and seasonal impact on the susceptible mos-
quitoes populations (thin line) over the year. The figure also shows the infected mosquitoes (thick line) amplified 20 times.Malaria Journal 2009, 8:296 http://www.malariajournal.com/content/8/1/296
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the year travelers arrive in the area, the model is essential
for those estimations.
The model for the resident population is a modification of
the classical Macdonald model [23]. The sensitivity of the
model's outcome for errors in the measurements of the
parameters was calculated. With exceptions of Macdonald
[23] and Burattini et al. [8] who analyzed the sensitivity of
the basic reproduction number to variation on the param-
eters, it seems to us that this is the first time the sensitivity
of other Macdonald's model outcomes is analyzed. The
results of this analysis point to a model that is very sensi-
tive to the mosquitoes biting rate, a, and natural mortality
rate, μM. A 1% error in the measurement of these parame-
ters assumed but perhaps this can be improved. The trave-
lers' population was approximately treated stochastically.
By this we mean that we considered the bites received by
a single individual are Poisson distributed with average
equals to the deterministic value of mosquitoes biting
rate, a, suffered by the resident population. In fact, the
number of bites suffered by each individual is the product
of the mosquitoes biting rate a  times the number of
infected mosquitoes in a certain area corresponding to the
mosquitoes flying range, which was considered to be
approximately constant. We also considered that the
probability of infection to humans, b, as Gamma distrib-
uted around the average value used for the resident popu-
lation and with a small variance.
The basic model could be applied to other regions where
local information on force of transmission, parasite rates
or similar malariometric data are available. Such risk esti-
mates would help the travel medicine provider with a bet-
ter starting point in their risk assessment and provide
travelers with a feel for what their malaria risk is and bal-
ance this with the appropriateness of chemoprophylaxis.
Appendix 1
The equations describing the model are given below. The
symbols describing the populations involved, the param-
eters and their values are described in the main text.
The evolution equations for the probe cohort are:
for
and θ(t - t0) is the Heaviside function.
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